Statins may reduce the risk of prostate cancer
The results of a long–term observational clinical study presented at the meeting of the American Association of Urologists (American Urological Association), held on April 25-30 this year in Chicago, suggest that patients taking statins have a lower risk of developing prostate cancer compared to those who do not take drugs of this group, - reports the website "Mayo Clinic".
The researchers observed 2,447 men aged 40-79 years for about 15 years. The results show that patients who took statins were 3 times less likely to be diagnosed with prostate cancer compared to those who did not take these drugs. "Our study clearly shows that the use of statins is associated with a threefold reduced risk of prostate cancer diagnosis," said Rodney Breau, head of the research group, in his comment.
Researcher Jennifer St. Sauver added that statins may have other positive sides for patients who take them for cardiovascular diseases or to lower cholesterol levels in the blood. However, as emphasized by J. Of course, it is necessary to get more information before recommending men to take statins in order to prevent such urological problems.